Key result
Patients with left ventricular dysfunction had significantly reduced global myocardial oxidative metabolism (Kmono 0.051 vs 0.059 min-1) and higher regional heterogeneity compared to healthy controls.
Why the study?
Does myocardial oxidative metabolism measured by 11C-acetate PET differ between ischemic and dilated cardiomyopathy?
Cross-Sectional (n=92)
Does myocardial oxidative metabolism measured by 11C-acetate PET differ between ischemic and dilated cardiomyopathy?
11C-acetate PET reveals that while both ischemic and dilated cardiomyopathy show globally reduced myocardial oxidative metabolism, ischemic cardiomyopathy exhibits greater metabolic heterogeneity.
Should not change cardiomyopathy management; hypothesis-generating for 11C-acetate PET heterogeneity differences between ischemic and dilated phenotypes.
BACKGROUND: The 11C-acetate positron emission tomography can estimate myocardial oxidative metabolism, but previous studies have only evaluated small populations and the difference between ischemic (ICM) and idiopathic dilated cardiomyopathy (DCM) has not been fully investigated. The present aims were to evaluate global and regional myocardial oxidative metabolism in a well-characterized, large population with left ventricular (LV) dysfunction in order to clarify the metabolic differences between ICM and DCM. METHODS AND RESULTS: Seventy-eight patients with ejection fraction (EF) < or =50% (33 ICM; 45 DCM) were compared with 14 healthy controls. Myocardial oxidative metabolism was estimated with a clearance rate constant (K(mono)) and the coefficient of variation (CV) of regional K(mono). Patients with LV dysfunction had reduced K(mono) and higher CV (p<0.05). In the comparison of oxidative alterations with clinical variables there was a weak correlation between K(mono) and LVEF (r=0.27). Although K(mono) was reduced in both ICM and DCM, CV was more pronouncedly increased in ICM (p=0.001). In multivariate analysis, the presence of left bundle branch block (LBBB) was an independent predictor of heterogeneous oxidative metabolism in DCM (R2=0.30, p<0.0001). CONCLUSIONS: Global reduction of myocardial oxidative metabolism occurred in both ICM and DCM. Heterogeneous oxidative metabolism was observed in these patients, especially those with ICM. Furthermore, LBBB was the independent predictor of heterogeneous oxidative metabolism in patients with DCM.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2008) conducted a cross-sectional in Ischemic and Dilated Cardiomyopathy (Left Ventricular Dysfunction) (n=92). Left ventricular dysfunction (Ischemic and Dilated Cardiomyopathy) vs. Healthy controls was evaluated on Global myocardial oxidative metabolism (clearance rate constant, Kmono) (p=<0.05). Patients with left ventricular dysfunction had significantly reduced global myocardial oxidative metabolism (Kmono 0.051 vs 0.059 min-1) and higher regional heterogeneity compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: